SEC Form 4 · accession 0001013606-17-000112
ENDOLOGIX INC /DE/ · ELGX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John D McDermott
Officer — Chief Executive Officer · Director
Period of report
Jun 19, 2017
Accepted (ET)
Jun 20, 2017 · 10:50 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001013606
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 19, 2017 | D | 48,222 | $0.00 | D | 743,126 | D |
Table II — derivative securities
No Table II lines on this filing.
Remarks
Shares subject to this Form 4 were granted as part of a performance stock unit granted May 28th, 2015. All shares granted have been forfeited due to the single performance milestone being deemed not achievable by the company.